Suit B E, Axelrod D, Moutsopoulos H M, Decker J L, Hooks J J
Clin Exp Rheumatol. 1983 Apr-Jun;1(2):133-5.
In this study, we show that sera from 2 of 13 patients with clinically active systemic lupus erythematosus (SLE) contained anti-interferon alpha (anti-IFN alpha) antibody. In contrast, anti-IFN alpha activity was not detected in sera from patients with clinically inactive SLE, rheumatoid arthritis (RA), Sjögren's syndrome, or in normal individuals. None of the sera exhibited anti-IFN gamma activity. These studies show that anti-IFN antibody, like IFN itself, is most frequently observed in patients with clinically active SLE. It is also possible that the presence of IFN-anti-IFN complexes may contribute, in part, to the pathogenesis of this disease.
在本研究中,我们发现13例临床活动期系统性红斑狼疮(SLE)患者中有2例的血清含有抗干扰素α(抗IFNα)抗体。相比之下,在临床非活动期SLE、类风湿关节炎(RA)、干燥综合征患者的血清或正常个体血清中未检测到抗IFNα活性。所有血清均未表现出抗IFNγ活性。这些研究表明,抗IFN抗体与IFN本身一样,最常见于临床活动期SLE患者。IFN-抗IFN复合物的存在也可能在一定程度上促成了该疾病的发病机制。